Shionogi & Co Stock

Shionogi & Co Revenue 2024

Shionogi & Co Revenue

435.08 B JPY

Ticker

4507.T

ISIN

JP3347200002

WKN

855648

In 2024, Shionogi & Co's sales reached 435.08 B JPY, a 1.97% difference from the 426.68 B JPY sales recorded in the previous year.

The Shionogi & Co Revenue history

YEARREVENUE (undefined JPY)GROSS MARGIN (%)
2027e473.8379,67
2026e454.5783,04
2025e446.3184,58
2024435.0886,76
2023426.6885,41
2022335.1483,47
2021297.1882,33
2020333.3782,97
2019367.9684,89
2018344.6778,56
2017338.8977,05
2016309.9775,88
2015273.9970,00
2014289.7273,08
2013282.972,23
2012267.2870,91
2011282.3571,05
2010278.572,62
2009227.5168,79
2008214.2767,99
2007199.7666,19
2006196.3965,01
2005199.3662,85

Shionogi & Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Shionogi & Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Shionogi & Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Shionogi & Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Shionogi & Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Shionogi & Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Shionogi & Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Shionogi & Co’s growth potential.

Shionogi & Co Revenue, EBIT and net profit per share

DateShionogi & Co RevenueShionogi & Co EBITShionogi & Co Net Income
2027e473.83 B JPY0 JPY176.03 B JPY
2026e454.57 B JPY136.11 T JPY164.28 B JPY
2025e446.31 B JPY126.36 T JPY163.34 B JPY
2024435.08 B JPY168.38 B JPY162.03 B JPY
2023426.68 B JPY159.25 B JPY184.97 B JPY
2022335.14 B JPY110.67 B JPY114.19 B JPY
2021297.18 B JPY118.72 B JPY111.86 B JPY
2020333.37 B JPY128.71 B JPY122.19 B JPY
2019367.96 B JPY163.6 B JPY137.19 B JPY
2018344.67 B JPY115.22 B JPY108.87 B JPY
2017338.89 B JPY108.18 B JPY83.88 B JPY
2016309.97 B JPY91.41 B JPY66.69 B JPY
2015273.99 B JPY50.37 B JPY44.06 B JPY
2014289.72 B JPY63.56 B JPY41.83 B JPY
2013282.9 B JPY58.85 B JPY66.73 B JPY
2012267.28 B JPY47 B JPY27.1 B JPY
2011282.35 B JPY46.89 B JPY20.03 B JPY
2010278.5 B JPY52.44 B JPY38.63 B JPY
2009227.51 B JPY31.93 B JPY15.66 B JPY
2008214.27 B JPY40.4 B JPY25.06 B JPY
2007199.76 B JPY28.86 B JPY18.59 B JPY
2006196.39 B JPY29.23 B JPY22.67 B JPY
2005199.36 B JPY28.73 B JPY18.86 B JPY

Shionogi & Co stock margins

The Shionogi & Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shionogi & Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shionogi & Co.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Shionogi & Co's sales revenue. A higher gross margin percentage indicates that the Shionogi & Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Shionogi & Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Shionogi & Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Shionogi & Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Shionogi & Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Shionogi & Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Shionogi & Co Margin History

Shionogi & Co Gross marginShionogi & Co Profit marginShionogi & Co EBIT marginShionogi & Co Profit margin
2027e86.76 %0 %37.15 %
2026e86.76 %29,942.79 %36.14 %
2025e86.76 %28,312.99 %36.6 %
202486.76 %38.7 %37.24 %
202385.41 %37.32 %43.35 %
202283.47 %33.02 %34.07 %
202182.33 %39.95 %37.64 %
202082.97 %38.61 %36.65 %
201984.89 %44.46 %37.28 %
201878.56 %33.43 %31.59 %
201777.05 %31.92 %24.75 %
201675.88 %29.49 %21.51 %
201570 %18.38 %16.08 %
201473.08 %21.94 %14.44 %
201372.23 %20.8 %23.59 %
201270.91 %17.59 %10.14 %
201171.05 %16.61 %7.09 %
201072.62 %18.83 %13.87 %
200968.79 %14.03 %6.88 %
200867.99 %18.85 %11.7 %
200766.19 %14.45 %9.31 %
200665.01 %14.88 %11.54 %
200562.85 %14.41 %9.46 %

Shionogi & Co Aktienanalyse

What does Shionogi & Co do?

The company Shionogi & Co Ltd is a Japanese pharmaceutical company based in Osaka. It was founded in 1878 and has since become a significant player in the industry. It currently employs over 6,000 employees worldwide and is listed on the Tokyo Stock Exchange. Shionogi is divided into several business segments that offer different products and services. The largest segment is the pharmaceutical division, which specializes in the development and marketing of drugs. The company has strong expertise in infectious diseases, pain management, and oncology, and operates in many countries worldwide. One flagship product is the antibiotic Cefditoren, used to treat various bacterial infections. In addition to the pharmaceutical division, Shionogi is also active in other areas. For example, the company offers diagnostic and laboratory services, operating multiple labs in Japan and other countries. Another business segment is the production and marketing of nutritional supplements, sold in Japan, China, and the USA. Shionogi's business model is based on extensive research and development, as well as strong brand positioning. The company invests a significant portion of its revenue each year in the research and development of new drugs and better treatment options for existing diseases. Thanks to the high quality of its products and strong brand, the company has a loyal customer base. In recent years, Shionogi has focused on international expansion opportunities and has expanded its activities in various regions. For example, it has partnered with US pharmaceutical company Purdue Pharma to develop and market a novel pain medication. Shionogi's annual revenue is around 1.5 billion euros. The company is particularly strong in Japan and other Asian countries, but is also active in the US and Europe. In the coming years, Shionogi aims to further expand its international business and solidify its position as a significant player in the industry. Key focuses will be on the launch of new products and finding treatments for previously incurable diseases. Overall, Shionogi is an innovative and successful company that utilizes its expertise in the pharmaceutical industry in various ways. With its dedicated employees and strong brand, it will continue to play an important role in the industry. Shionogi & Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Shionogi & Co's Sales Figures

The sales figures of Shionogi & Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Shionogi & Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Shionogi & Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Shionogi & Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Shionogi & Co stock

How much revenue did Shionogi & Co generate this year?

Shionogi & Co has achieved a revenue of 435.08 B JPY this year.

How much was the turnover of the company Shionogi & Co compared to the previous year?

The revenue of Shionogi & Co has increased by 1.97% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Shionogi & Co?

The revenue of Shionogi & Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Shionogi & Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Shionogi & Co so important for investors?

The revenue of Shionogi & Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Shionogi & Co pay?

Over the past 12 months, Shionogi & Co paid a dividend of 113.33 JPY . This corresponds to a dividend yield of about 5.26 %. For the coming 12 months, Shionogi & Co is expected to pay a dividend of 117.56 JPY.

What is the dividend yield of Shionogi & Co?

The current dividend yield of Shionogi & Co is 5.26 %.

When does Shionogi & Co pay dividends?

Shionogi & Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Shionogi & Co?

Shionogi & Co paid dividends every year for the past 23 years.

What is the dividend of Shionogi & Co?

For the upcoming 12 months, dividends amounting to 117.56 JPY are expected. This corresponds to a dividend yield of 5.45 %.

In which sector is Shionogi & Co located?

Shionogi & Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shionogi & Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shionogi & Co from 12/2/2024 amounting to 28.333 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Shionogi & Co pay the last dividend?

The last dividend was paid out on 12/2/2024.

What was the dividend of Shionogi & Co in the year 2023?

In the year 2023, Shionogi & Co distributed 150 JPY as dividends.

In which currency does Shionogi & Co pay out the dividend?

The dividends of Shionogi & Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shionogi & Co

Our stock analysis for Shionogi & Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shionogi & Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.